Breaking News Instant updates and real-time market news.

ACHC

Acadia

$39.52

-0.69 (-1.72%)

, CAH

Cardinal Health

$48.96

-1.84 (-3.62%)

04:55
08/09/18
08/09
04:55
08/09/18
04:55

Leerink to hold a tour

Heart of Healthcare Facilities Bus Tour travels throughout Nashville, TN on August 8-9.

ACHC

Acadia

$39.52

-0.69 (-1.72%)

CAH

Cardinal Health

$48.96

-1.84 (-3.62%)

CYH

Community Health

$3.02

-0.02 (-0.66%)

LPNT

LifePoint

$64.58

0.025 (0.04%)

  • 15

    Aug

  • 22

    Aug

  • 22

    Aug

ACHC Acadia
$39.52

-0.69 (-1.72%)

08/01/18
BMOC
08/01/18
DOWNGRADE
BMOC
Market Perform
Acadia downgraded to Market Perform from Outperform at BMO Capital
08/01/18
BMOC
08/01/18
DOWNGRADE
Target $40
BMOC
Market Perform
Acadia downgraded to Market Perform at BMO Capital on rising risks
As reported earlier, BMO Capital analyst Matt Borsch downgraded Acadia to Market Perform from Outperform and lowered his price target to $40 from $45. The analyst cites risks to the company's strong U.S. business that "may include pressure on length of stay from managed care as well as labor/wage cost pressure". Borsch is also concered with Acadia's U.K. industry dynamics, which he expects to remain "challenging" and weighed down by volume and business mix.
08/01/18
LEER
08/01/18
NO CHANGE
Target $42
LEER
Market Perform
Acadia selloff 'a bit overdone,' says Leerink
Leerink analyst Ana Gupte lowered her price target for Acadia to $42 from $44, while reiterating a Market Perform rating on the shares. Nonetheless, the analyst views the 8% selloff as overdone after U.S. trends were below expectations with beds adds expected to ramp in 2H18-2019, while the U.K. showed continued turnaround with the potential for a dilutive share raise from a larger acquisition this year.
08/03/18
JEFF
08/03/18
NO CHANGE
Target $47
JEFF
Buy
Acadia earning selloff brings buying opportunity, says Jefferies
Acadia Healthcare's guidance reduction and the deceleration in its U.S. organic growth merited a modest stock pullback, but the 7% post-earnings selloff is an "overreaction that has opened up a buying opportunity," Jefferies analyst Brian Tanquilut tells investors in a research note. He believes the company's U.S. same-store volume growth should accelerate in Q3 and that management's fiscal 2018 guidance is achievable. The analyst keeps a Buy rating on Acadia with a $47 price target. Further, he notes that investors are asking if the stock pullback and improvement of the U.K. business open the door to a strategic review. Tanquilut says his analysis indicates Acadia is worth $53-$55 per share in a leveraged buyout. The U.K. business is not in the analyst's model.
CAH Cardinal Health
$48.96

-1.84 (-3.62%)

06/28/18
JPMS
06/28/18
NO CHANGE
JPMS
Amazon deal creates significant overhang on Rx channel sentiment, says JPMorgan
JPMorgan Analyst Lisa Gill said Amazon's (AMZN) agreement to acquire PillPack is expected to drive a "significant overhang" on sentiment across the prescription channel, even though she doesn't expect PillPack to capture a material share of the market in the near term. While the deal establishes an initial foothold for Amazon in the mail pharmacy space, she thinks it will take time to scale up and she does not believe PillPack's unit dose packaging technology is unique. Gill also noted that Express Scripts (ESRX) said it would remove PillPack from its pharmacy network in 2016 on allegations it had misrepresented itself as a retail pharmacy and not a mail pharmacy, though within weeks PillPack was added back by the PBM. Shares of retail pharmacy operators CVS Health (CVS), Walgreens (WBA) and Rite Aid (RAD) have all been pressured by the news of Amazon's deal, as have the shares of drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK). Diplomat Pharmacy (DPLO), an operator of a specialty pharmacy, is also sharply lower following the announcement from Amazon.
05/04/18
RBCM
05/04/18
NO CHANGE
Target $62
RBCM
Sector Perform
Cardinal Health price target lowered to $62 from $81 at RBC Capital
RBC Capital analyst George Hill lowered his price target on Cardinal Health to $62 and kept his Sector Perform rating after its Q3 earnings miss as a result of an inventory write-down in its Cordis business along with a related tax expense. The analyst also attributes his increased pessimism to the management's discussion of "the loss of PharMerica and a higher-than-normal number of customer repricing arrangements".
05/04/18
LEER
05/04/18
NO CHANGE
Target $65
LEER
Outperform
Cardinal Health FY19 guidance a 'clearing event,' says Leerink
Leerink analyst David Larsen believes that while Cardinal Health's Q3 results were disappointing, the quarter and the FY19 guidance were "a clearing event" for the stock. The Medical segment ex-Cordis appears to be performing well and the core Pharma business had another quarter of strong performance, said Larsen, who keeps an Outperform rating on Cardinal Health but lowered his price target on the stock to $65 from $75.
05/07/18
MZHO
05/07/18
NO CHANGE
Target $61
MZHO
Neutral
Cardinal Health price target lowered to $61 from $73 at Mizuho
Mizuho analyst Ann Hynes lowered her price target for Cardinal Health to $61 citing the company's "soft" outlook. Cardinal's reduced guidance highlights the company's lack of earnings visibility and challenges it faces with Cordis, Hynes tells investors in a research note. She keeps a Neutral rating on the shares.
CYH Community Health
$3.02

-0.02 (-0.66%)

01/03/18
GSCO
01/03/18
INITIATION
GSCO
Sell
Community Health initiated with a Sell at Goldman Sachs
Goldman analyst Stephen Tanal initiated Community Health with a Sell and $3 price target due to its group-low EBITDA margin, weak CROCI outlook, and heavy debt load.
07/23/18
GSCO
07/23/18
NO CHANGE
GSCO
Deal activity could pick up after LifePoint takeout, says Goldman Sachs
Goldman Sachs analyst Stephen Tanal said that although the hospital industry appears to be grappling with secular challenges, hospitals are still generating meaningful and relatively predictable cash flows and mostly trading at lower multiples than other stocks in the broader healthcare space. Given an environment in which rates are low, credit is available and financial buyers have "dry powder," he believes deal activity could pick up following LifePoint's (LPNT) agreement to be bought by Apollo Global (APO) affiliates. Community Health (CYH), like LifePoint, should be "relevant for years to come" as its hospitals are often the sole provider of acute healthcare services in small towns or rural areas, according to Tanal. HCA Healthcare (HCA), in contrast, is positioned in fast-growing markets with high levels of commercial coverage, Tanal added.
01/30/18
WELS
01/30/18
INITIATION
Target $4.5
WELS
Underperform
Community Health resumed with an Underperform at Wells Fargo
Wells Fargo analyst Peter Costa resumed coverage of Community Health Systems with an Underperform rating and $4.50 price target. The analyst believes the company's balance sheet issues are "sufficiently problematic that the equity is likely to be diluted substantially and a turnaround seems far off."
03/23/18
MZHO
03/23/18
INITIATION
Target $4.5
MZHO
Neutral
Community Health resumed with a Neutral at Mizuho
Mizuho analyst Ann Hynes resumed coverage of Community Health Systems with a Neutral rating and $4.50 price target.
LPNT LifePoint
$64.58

0.025 (0.04%)

07/24/18
RBCM
07/24/18
DOWNGRADE
Target $65
RBCM
Sector Perform
LifePoint downgraded to Sector Perform at RBC Capital after Apollo acquisition
As reported earlier, RBC Capital analyst Frank Morgan downgraded LifePoint (LPNT) to Sector Perform from Outperform but raised his price target to $65 from $63 after the company's announced $65 per share acquisition by Apollo Global Management (APO). The analyst notes the deal is expected to close in the next few months.
07/24/18
BMOC
07/24/18
NO CHANGE
Target $62
BMOC
Market Perform
LifePoint price target raised to $62 from $51 at BMO Capital
BMO Capital analyst Matt Borsch raised his price target on LifePoint (LPNT) to $62 and kept his Market Perform rating after the proposed transaction for the company to be taken private by the Apollo Global (APO) affiliate RCCH HealthCare Partners at $65 per share. The analyst says his price target reflects the acquisition price blended with some uncertainty regarding the deal, even as he views the terms of the offer as attractive to LifePoint shareholders against the"backdrop of reimbursement and volume pressures that challenge acute care hospitals".
07/24/18
FBCO
07/24/18
NO CHANGE
Target $65
FBCO
Neutral
LifePoint price target raised to $65 from $58 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for LifePoint (LPNT) to $65 from $58 to reflect deal price after the company agreed to be acquired by Apollo Global (APO) affiliates for $65 per share. The analyst reiterates a Neutral rating on LifePoint shares.
07/24/18
BARD
07/24/18
DOWNGRADE
Target $65
BARD
Neutral
LifePoint downgraded to Neutral from Outperform at Baird
Baird analyst Matthew Gillmor downgraded LifePoint Health (LPNT) to Market Perform after the company agreed to be acquired by Apollo Global (APO) affiliates for $65 per share.

TODAY'S FREE FLY STORIES

MSI

Motorola Solutions

$129.97

0.72 (0.56%)

18:48
11/16/18
11/16
18:48
11/16/18
18:48
Hot Stocks
Motorola Solutions: ITC confirms Hytera products infringe Motorola patents »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Dec

  • 19

    Dec

PCG

PG&E

$24.39

6.62 (37.25%)

18:23
11/16/18
11/16
18:23
11/16/18
18:23
Periodicals
CPUC isn't ruling out board shuffle, breakup for PG&E, Bloomberg says »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.04

0.05 (0.38%)

18:00
11/16/18
11/16
18:00
11/16/18
18:00
Periodicals
Barrick Gold looking to add more copper, bullion assets, Reuters reports »

Barrick Gold is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$33.05

0.165 (0.50%)

17:57
11/16/18
11/16
17:57
11/16/18
17:57
Hot Stocks
Aqua America CEO acquires over 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

, XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

17:39
11/16/18
11/16
17:39
11/16/18
17:39
General news
Week ending ETF scorecard: Real Estate leads, Consumer Discretionary slumps »

S&P500 SECTORS: Real…

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

XLU

Utilities SPDR

$54.86

0.77 (1.42%)

XLI

Industrial Select Sector SPDR

$72.00

(0.00%)

XLV

Health Care Select Sector SPDR

$92.05

0.91 (1.00%)

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

XLP

Consumer Staples Sector SPDR

$56.04

0.15 (0.27%)

XLE

Energy Select Sector SPDR

$67.23

0.76 (1.14%)

XLC

Communication Services Select Sector SPDR Fund

$44.88

-0.2 (-0.44%)

XLK

Technology Select Sector SPDR

$68.22

-0.1 (-0.15%)

XLY

Consumer Discretionary Sector SPDR

$106.37

-0.43 (-0.40%)

GLD

SPDR Gold Shares

$115.56

0.82 (0.71%)

SLV

iShares Silver Trust

$13.55

0.115 (0.86%)

USO

United States Oil Fund

$12.07

0.08 (0.67%)

UNG

United States Natural Gas Fund

$35.43

3.63 (11.42%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.24

-0.27 (-0.32%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$111.73

0.23 (0.21%)

TLT

iShares 20+ Year Treasury Bond Fund

$114.65

0.61 (0.53%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.13

0.3 (0.30%)

SHY

iShares 1-3 Year Treasury Bond

$83.13

0.08 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$17.02

0.23 (1.37%)

17:36
11/16/18
11/16
17:36
11/16/18
17:36
Hot Stocks
Aquestive receives CRL from FDA for tadalafil oral film »

Aquestive Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

DAKT

Daktronics

$7.67

0.07 (0.92%)

17:35
11/16/18
11/16
17:35
11/16/18
17:35
Hot Stocks
Daktronics adopts new shareholder rights agreement »

Daktronics announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TI

Telecom Italia

$6.02

0.12 (2.03%)

17:33
11/16/18
11/16
17:33
11/16/18
17:33
Periodicals
Gubitosi viewed as frontrunner for Telecom Italia CEO job, Reuters says »

Veteran Italian manager…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$18.77

-0.59 (-3.05%)

17:30
11/16/18
11/16
17:30
11/16/18
17:30
Hot Stocks
Maxar Technologies shareholders approve U.S. domestication »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$1.83

(0.00%)

17:28
11/16/18
11/16
17:28
11/16/18
17:28
Syndicate
Breaking Syndicate news story on Plug Power »

Plug Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$4.55

-0.02 (-0.44%)

17:22
11/16/18
11/16
17:22
11/16/18
17:22
Syndicate
Breaking Syndicate news story on GlobalSCAPE »

GlobalSCAPE files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQIX

Equinix

$388.18

2.67 (0.69%)

17:19
11/16/18
11/16
17:19
11/16/18
17:19
Hot Stocks
Equinix's Lee sells 2,792 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

LMT

Lockheed Martin

$301.06

-4.42 (-1.45%)

17:17
11/16/18
11/16
17:17
11/16/18
17:17
Hot Stocks
Lockheed Martin awarded $282.09M Naval Sea Systems Command contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$2.56

0.045 (1.79%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Hot Stocks
Teligent receives notification of deficiency from Nasdaq »

Teligent said that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$1.82

0.07 (4.00%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Syndicate
Breaking Syndicate news story on Staffing 360 Solutions »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

IMMR

Immersion

$9.56

-0.14 (-1.44%)

17:12
11/16/18
11/16
17:12
11/16/18
17:12
Hot Stocks
Breaking Hot Stocks news story on Immersion »

Man Group reports 4.84%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$11.95

0.74 (6.60%)

17:10
11/16/18
11/16
17:10
11/16/18
17:10
Hot Stocks
Breaking Hot Stocks news story on Athenex »

Perceptive Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 02

    Dec

TSRO

Tesaro

$34.96

8.39 (31.58%)

17:08
11/16/18
11/16
17:08
11/16/18
17:08
Recommendations
Tesaro analyst commentary at Piper Jaffray »

Piper Jaffray says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

EEI

Ecology & Environment

$10.50

-2 (-16.00%)

17:05
11/16/18
11/16
17:05
11/16/18
17:05
Hot Stocks
Ecology & Environment receives noncompliance notice from Nasdaq »

Ecology and Environment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEE

Ameren

$69.29

0.01 (0.01%)

16:58
11/16/18
11/16
16:58
11/16/18
16:58
Hot Stocks
Ameren exec Nelson sells $690,000 worth of common shares »

Ameren SVP, general…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQS

Equus II Inc

$1.86

(0.00%)

16:56
11/16/18
11/16
16:56
11/16/18
16:56
Hot Stocks
Equus II Inc reports net assets of $46.6M as of September 30 »

Equus Total Return…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VAPO

Vapotherm

$17.10

-0.42 (-2.40%)

16:56
11/16/18
11/16
16:56
11/16/18
16:56
Hot Stocks
Breaking Hot Stocks news story on Vapotherm »

Redmile Group reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

COTY

Coty

$9.09

0.39 (4.48%)

16:55
11/16/18
11/16
16:55
11/16/18
16:55
Hot Stocks
Coty CEO acquires 2.3M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

NVS

Novartis

$87.74

0.52 (0.60%)

16:54
11/16/18
11/16
16:54
11/16/18
16:54
Upgrade
Novartis rating change at Goldman Sachs »

Novartis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

VIAB

Viacom

$33.00

1.13 (3.55%)

16:52
11/16/18
11/16
16:52
11/16/18
16:52
Syndicate
Breaking Syndicate news story on Viacom »

Viacom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 04

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.